Phathom Pharmaceuticals, Inc. 13F holders
161 funds reported a position in Phathom Pharmaceuticals, Inc. in their 13F for the quarter ended 30 June 2026, together 72.1 million shares worth $782.1 million. Against the quarter before, 18 opened a position, 58 added, 50 trimmed and 32 sold out; together they bought a net 2.9 million shares. The largest holders: Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd and BlackRock, Inc.
Funds holding161-13 on Q1 2026
Shares they held72.1Mworth $782.1 million
Net bought on the quarter2.9M sharesabout $31.6 million at the funds' values
Funds buying to selling76 to 82opened or added, to cut or sold
Opened 18Added 58Held 34Trimmed 50Sold out 32
What each fund did in PHAT against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in PHAT in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 23 reported a position in Phathom Pharmaceuticals, Inc.: 3 opened one, 11 added, 1 trimmed and 4 sold out, a net 1.8 million shares bought.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Wasatch Advisors LP | +1,635,185 | 2,942,432 | added | 13F |
| Profund Advisors LLC | +104,054 | 121,331 | added | 13F |
| Hennion & Walsh Asset Management, Inc. | +65,114 | 392,392 | added | 13F |
| State of Alaska, Department of Revenue | +3,492 | 3,492 | new | 13F |
| China Universal Asset Management Co., Ltd. | +2,068 | 14,761 | added | 13F |
| Nisa Investment Advisors, LLC | -1,512 | 428 | trimmed | 13F |
| Mirae Asset Global Investments Co., Ltd. | +567 | 4,134 | added | 13F |
| Wealth Enhancement Advisory Services, LLC | +563 | 19,294 | added | 13F |
| Sterling Capital Management LLC | +399 | 1,155 | added | 13F |
| Caitong International Asset Management Co., Ltd | +284 | 284 | new | 13F |
| GF Fund Management Co. Ltd | +149 | 1,818 | added | 13F |
| Gamma Investing LLC | +105 | 505 | added | 13F |
| Farther Finance Advisors, LLC | +54 | 396 | added | 13F |
| True Wealth Design, LLC | +7 | 95 | added | 13F |
| SJS Investment Consulting Inc. | +2 | 2 | new | 13F |
| MassMutual Private Wealth & Trust, FSB | -427 | 0 | sold out | 13F |
| State of Wyoming | -17,639 | 0 | sold out | 13F |
| Stone House Investment Management, LLC | -8 | 0 | sold out | 13F |
| Y-Intercept (Hong Kong) Ltd | -39,845 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 7 reported a position in Phathom Pharmaceuticals, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Millennium Management, 3.4 million shares worth $36.6 million, 0.0% of its reported book. New this quarter: Point72 Asset Management. In the quarter, 3 funds added or opened a position and 4 trimmed or sold out; together they bought a net 123,348 shares, about $1.3 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Millennium Management | 3,375,834 | $36.6 million | 0.0% | -647,075 | trimmed | 30 June 2026 | 13F |
| Geode Capital Management | 1,315,687 | $14.3 million | 0.0% | -12,358 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 1,022,193 | $11.1 million | 0.0% | +1,022,193 | new | 30 June 2026 | 13F |
| Two Sigma Investments | 519,076 | $5.6 million | 0.0% | +36,940 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 226,400 | $2.5 million | 0.0% | -79,400 | trimmed | 30 June 2026 | 13F |
| Citadel Advisors | 184,901 | $2.0 million | 0.0% | -198,157 | trimmed | 30 June 2026 | 13F |
| FMR LLC | 8,230 | $89,290 | 0.0% | +1,205 | added | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 12,466,489 | 17.30% | $135.3 million | 2.95% | no change | 13F |
| Medicxi Ventures Management (Jersey) Ltd | 7,464,572 | 10.36% | $81.0 million | 45.65% | no change | 13F |
| BlackRock, Inc. | 4,525,129 | 6.28% | $49.1 million | 0.00% | +463,133 | 13F |
| Invesco Ltd. | 4,029,731 | 5.59% | $43.7 million | 0.00% | -292,329 | 13F |
| Carlyle Group Inc. | 3,496,808 | 4.85% | $37.9 million | 0.38% | no change | 13F |
| Millennium Management LLC | 3,375,834 | 4.68% | $36.6 million | 0.03% | -647,075 | 13F |
| Vanguard Capital Management LLC | 2,656,944 | 3.69% | $28.8 million | 0.00% | +73,308 | 13F |
| GW&K Investment Management, LLC | 2,166,838 | 3.01% | $23.5 million | 0.18% | +745,729 | 13F |
| Franklin Resources Inc. | 1,970,828 | 2.73% | $21.4 million | 0.01% | +976,324 | 13F |
| NEA Management Company, LLC | 1,960,169 | 2.72% | $21.3 million | 1.34% | no change | 13F |
| 683 Capital Management, LLC | 1,850,000 | 2.57% | $20.1 million | 1.93% | no change | 13F |
| Goldman Sachs Group Inc. | 1,778,032 | 2.47% | $19.3 million | 0.00% | +1,151,836 | 13F |
| State Street Corp. | 1,586,323 | 2.20% | $17.2 million | 0.00% | +199,433 | 13F |
| Catalys Pacific, LLC | 1,493,854 | 2.07% | $16.2 million | 7.06% | no change | 13F |
| Nomura Asset Management International Inc. | 1,462,738 | 2.03% | $15.9 million | 0.02% | +257,369 | 13F |
| Geode Capital Management, LLC | 1,315,687 | 1.83% | $14.3 million | 0.00% | -12,358 | 13F |
| Wasatch Advisors LP | 1,307,247 | 1.81% | $14.2 million | 0.09% | -33,669 | 13F |
| Ensign Peak Advisors, Inc | 1,051,913 | 1.46% | $11.4 million | 0.02% | -575,893 | 13F |
| Propel Bio Management, LLC | 1,050,358 | 1.46% | $11.4 million | 5.96% | +209,086 | 13F |
| Point72 Asset Management, L.P. | 1,022,193 | 1.42% | $11.1 million | 0.02% | new | 13F |
| Vanguard Portfolio Management LLC | 796,631 | 1.11% | $8.6 million | 0.00% | +130,602 | 13F |
| SummitTX Capital, L.P. | 789,550 | 1.10% | $8.6 million | 0.23% | -206,335 | 13F |
| HSBC Holdings PLC | 709,695 | 0.98% | $7.7 million | 0.00% | new | 13F |
| Marshall Wace, LLP | 666,090 | 0.92% | $7.2 million | 0.01% | -194,602 | 13F |
| EcoR1 Capital, LLC | 625,000 | 0.87% | $6.8 million | 0.34% | no change | 13F |
| Perceptive Advisors LLC | 532,000 | 0.74% | $5.8 million | 0.09% | -393,000 | 13F |
| Two Sigma Investments, LP | 519,076 | 0.72% | $5.6 million | 0.00% | +36,940 | 13F |
| Northern Trust Corp. | 458,301 | 0.64% | $5.0 million | 0.00% | +43,345 | 13F |
| StepStone Group LP | 422,085 | 0.59% | $4.6 million | 0.21% | no change | 13F |
| Charles Schwab Investment Management Inc. | 419,094 | 0.58% | $4.5 million | 0.00% | +10,079 | 13F |
| Woodline Partners LP | 369,052 | 0.51% | $4.0 million | 0.01% | no change | 13F |
| Vanguard Fiduciary Trust Co. | 354,573 | 0.49% | $3.8 million | 0.00% | +15,860 | 13F |
| Hennion & Walsh Asset Management, Inc. | 327,278 | 0.45% | $3.6 million | 0.10% | +181,346 | 13F |
| Ameriprise Financial Inc. | 293,979 | 0.41% | $3.2 million | 0.00% | +39,760 | 13F |
| JPMorgan Chase & Co. | 275,251 | 0.38% | $3.0 million | 0.00% | -12,179 | 13F |
| Simplify Asset Management Inc. | 249,267 | 0.35% | $2.7 million | 0.04% | -13,119 | 13F |
| Renaissance Technologies LLC | 226,400 | 0.31% | $2.5 million | 0.00% | -79,400 | 13F |
| Jane Street Group, LLC | 212,706 | 0.30% | $2.3 million | 0.00% | new | 13F |
| UBS Group AG | 204,573 | 0.28% | $2.2 million | 0.00% | -155,798 | 13F |
| NewEdge Advisors, LLC | 203,962 | 0.28% | $2.2 million | 0.01% | +20,962 | 13F |
| Avidity Partners Management LP | 200,000 | 0.28% | $2.2 million | 0.35% | -298,780 | 13F |
| Morgan Stanley | 199,909 | 0.28% | $2.2 million | 0.00% | +123,228 | 13F |
| Jump Financial, LLC | 191,866 | 0.27% | $2.1 million | 0.02% | +165,421 | 13F |
| Opaleye Management Inc. | 185,589 | 0.26% | $2.0 million | 0.18% | new | 13F |
| Citadel Advisors LLC | 184,901 | 0.26% | $2.0 million | 0.00% | -198,157 | 13F |
| Trexquant Investment LP | 173,884 | 0.24% | $1.9 million | 0.01% | -119,421 | 13F |
| Jones Hill Capital LP | 161,486 | 0.22% | $1.8 million | 0.37% | new | 13F |
| Bank of New York Mellon Corp | 152,313 | 0.21% | $1.7 million | 0.00% | +28,295 | 13F |
| Wells Fargo & Company | 152,002 | 0.21% | $1.6 million | 0.00% | +105,889 | 13F |
| Bank of America Corp. | 151,015 | 0.21% | $1.6 million | 0.00% | -57,100 | 13F |
The 50 largest of the 161 funds that reported a position in PHAT in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on PHAT
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 480,800 | $5.2 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 31,100 | $337,435 | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 29 July 2026 | 13G | BlackRock, Inc. and 1 other | 4.4 million | 5.5% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 20 July 2026 | 13G/A | Millennium Management LLC and 5 others | 3.4 million | 4.2% | 30 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 12 March 2026 | 13G | Millennium Management LLC and 5 others | 4.2 million | 5.3% | 6 March 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 27 January 2026 | 13G/A | Integrated Core Strategies (US) LLC and 7 others | 2.1 million | 2.7% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 4 November 2025 | 13D/A | Frazier Life Sciences Public Fund, L.P. and 16 others | 6.0 million | 8.6% | 1 November 2025 | Item 4 is hereby amended to remove references to "FLSPOF" and the "FLSPOF Shares" from the first paragraph. | EDGAR |
| 3 November 2025 | 13G/A | Integrated Core Strategies (US) LLC and 7 others | 5.1 million | 7.1% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 22 September 2026 | 1,968 | $7.45 | SEC |
| 21 September 2026 | 5,115 | $7.48 | SEC |
| 17 September 2026 | 37 | $7.69 | SEC |
| 8 September 2026 | 336 | $9.50 | SEC |
| 27 August 2026 | 155 | $8.77 | SEC |
| 25 August 2026 | 21,610 | $8.66 | SEC |
| 24 August 2026 | 2,000 | $8.87 | SEC |
| 19 August 2026 | 613 | $9.25 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.